Skip to main content
. 2021 Nov 22;6:138. Originally published 2021 Jun 3. [Version 2] doi: 10.12688/wellcomeopenres.16701.2

Table 1. Characteristics of studies used to fit the model.

Strain Author (year
published)
Pubmed ID Sample
size
Country/
region
Years sampled Assay Antigen Assay cut-off
HCoV-HKU1 Chan (2009) 19342289 709 Hong Kong Not specified ELISA (IgG) S protein Mean + 3SD (OD>0.495)
Zhou (2013) a 24040960 789 China 1999 – 2011 IFA (IgG) S protein >1:20
HCoV-OC43 Zhou (2013) a 24040960 789 China 1999 – 2011 IFA (IgG) S protein >1:20
Monto (1974) c 4816305 910 USA 1965 – 1969 CF or HI Whole virus <1:8 to >1:8 or 4-fold rise
Sarateanu (1980) 6248465 3,016 Germany 1974 – 1976 HI Whole virus >1:8
HCoV-NL63 Shao (2007) b 17889596 243 USA 2003 – 2004 ELISA (IgG) N protein OD>0.2 at dilution of 1:80 or greater
Zhou (2013) a 24040960 789 China 1999 – 2011 IFA (IgG) S protein >1:20
HCoV-229E Shao (2007) b 17889596 243 USA 2003 – 2004 ELISA (IgG) N protein OD>0.2 at dilution of 1:80 or greater
Zhou (2013) a 24040960 789 China 1999 – 2011 IFA (IgG) S protein >1:20
Cavallaro (1970) c 5504709 307 USA 1966 Neutralization Whole virus >1:4

Human coronavirus (HCoV), Enzyme-linked immunosorbent assays (ELISA), immunofluorescence assays (IFA), complement fixation (CF), hemagglutination inhibition assays (HI), Immunoglobulin G (IgG), standard deviation (SD), optical density (OD). Studies which occurred in the same setting are denoted by the superscripts, a, b and c.